Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01590446 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers
A Phase 1 study, sponsored by BioMarin Pharmaceutical.
- Completed
- Registry status
- Phase 1
- Development phase
- 74
- Enrollment target
NCT01590446: Completed Phase 1 study, sponsored by BioMarin Pharmaceutical.
NCT01590446 is a Phase 1 study that has completed, run by BioMarin Pharmaceutical. The registered enrollment target is 74 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01590446, a Phase 1 study, has completed, sponsored by BioMarin Pharmaceutical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to measure how much of the study drug gets into the blood- stream and how long it takes the body to get rid of it when given as a single dose. Information about any side effects that may occur will also be collected.
Interventions
- DRUG Normal Saline
- DRUG BMN 111
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
What the finished NCT01590446 record still lists
NCT01590446 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% higher).
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT01590446 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01590446 about?
NCT01590446 is a clinical study titled "A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers". The purpose of this study is to measure how much of the study drug gets into the blood- stream and how long it takes the body to get rid of it when given as a single dose. Information about any side effects that may occur will also be collected.
What is the current status of trial NCT01590446?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2012-02. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01590446?
The interventions under investigation include: Normal Saline (DRUG), BMN 111 (DRUG).
Who is sponsoring clinical trial NCT01590446?
This trial is sponsored by BioMarin Pharmaceutical, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01590446's enrollment target sits among peer trials
74 725th of 2000 higher than 1,269 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia